0001437749-11-002318.txt : 20110414 0001437749-11-002318.hdr.sgml : 20110414 20110414164716 ACCESSION NUMBER: 0001437749-11-002318 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110414 ITEM INFORMATION: Termination of a Material Definitive Agreement ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20110414 DATE AS OF CHANGE: 20110414 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUCOR INC CENTRAL INDEX KEY: 0000736822 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 222408354 STATE OF INCORPORATION: GA FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-14820 FILM NUMBER: 11760097 BUSINESS ADDRESS: STREET 1: 3130 GATWAY STREET 2: PO BOX 5625 CITY: NORCROSS STATE: GA ZIP: 30091 BUSINESS PHONE: 770 441 2051 MAIL ADDRESS: STREET 1: 3130 GATEWAY DR STREET 2: P O BOX 5625 CITY: NORCROSS STATE: GA ZIP: 30091-5625 8-K 1 immucor_8k-041411.htm FORM 8-K immucor_8k-041411.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
__________________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  April 14, 2011
 
IMMUCOR, INC.
(Exact name of registrant as specified in its charter)
 
Georgia   0-14820   22-2408354
(State or other jurisdiction   (Commission   (IRS Employer
of incorporation)   File Number)   Identification No.)
 
3130 Gateway Drive, Norcross, Georgia   30071
(Address of principal executive offices)   (Zip Code)
 
Registrant's telephone number, including area code: (770) 441-2051

Not Applicable
(Former name or former address,
if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 
 
Item 1.02. 
Termination of a Material Definitive Agreement.
 
On April 14, 2011, Immucor, Inc. (the “Company”) accepted the resignation of Geoffrey S. Crouse from his position as Executive Vice President and Chief Operating Officer of the Company.  In connection with Mr. Crouse’s resignation, the Company and Mr. Crouse terminated the Amended and Restated Employment Agreement between them dated August 1, 2010 (the “Agreement”).  The Company incurred costs of approximately $2.4 million related to the termination of the Agreement.  The Agreement is filed as Exhibit 10.1 and the terms and conditions of the Agreement are incorporated herein by reference.
 
Item 5.02(b). 
Departure of Certain Officers.
 
As described above, on April 14, 2011 the Company accepted the resignation of Geoffrey S. Crouse from his position as Executive Vice President and Chief Operating Officer of the Company.
 
Item 9.01. 
Financial Statements and Exhibits

(d)           Exhibits

10.1
Amended and Restated Employment Agreement, dated as of August 1, 2010, by and between the Company and Geoffrey S. Crouse (incorporated by reference to Exhibit 10.1 to Immucor, Inc.’s Current Report on Form 8-K filed on August 17, 2010).

 
 

 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
IMMUCOR, INC.
 
       
Date:  April 14, 2011
By:
/s/ Philip H. Moïse  
    Philip H. Moïse  
    Executive Vice President and General Counsel